Position in ABSI
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$2,005
+$1,486 QoQ
Shares Held
173
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#191
of 195 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Noble Wealth Management PBC holds $64,017 across 8 Biotechnology names. ABSI ranks #3 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
840 | $46,149 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
274 | $10,688 | |
| 3 | ABSI |
Absci Corp
This page
|
173 | $2,005 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3 | $1,490 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
3 | $1,115 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8 | $973 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
10 | $815 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
9 | $782 |
All Filings in ABSI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,005 | 173 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $519 | 173 | Shares | Sole | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||